Brief: Kancera Q4 Operating Loss Narrows To SEK 7.5 Million
Feb 21 (Reuters) - Kancera AB KANC.ST :
* Q4 NET SALES SEK 0 VERSUS SEK 0.3 MILLION YEAR AGO
* Q4 OPERATING LOSS SEK 7.5 MILLION VERSUS LOSS SEK 12.4
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr57XvJX
Further company coverage: KANC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing